The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Galfer 140 mg/5ml Oral Suspension

140 mg/5ml Oral suspension

Clonmel Healthcare LtdPA0126/314/002

Main Information

Trade NameGalfer 140 mg/5ml Oral Suspension
Active SubstancesFerrous fumarate Ph.Eur.
Strength140 mg/5ml
Dosage FormOral suspension
Licence HolderClonmel Healthcare Ltd
Licence NumberPA0126/314/002

Group Information

ATC CodeB03AA Iron bivalent, oral preparations
B03AA02 ferrous fumarate


Licence Issued25/07/1988
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceNone
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back